Related Experiment Video

Updated: Jul 11, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

No responses to oral etoposide in 15 patients with recurrent brain tumors

D N Korones1, P G Fisher, K J Cohen

  • 1Children's Hospital at Strong and The University of Rochester Cancer Center, NY 14642, USA. david_korones@urmc.rochester.edu

Medical and Pediatric Oncology
|July 6, 2000
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Related Experiment Videos

Last Updated: Jul 11, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma.

AJNR. American journal of neuroradiology·2021

Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study.

AJNR. American journal of neuroradiology·2020

MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.

AJNR. American journal of neuroradiology·2018

MRI surrogates for molecular subgroups of medulloblastoma.

AJNR. American journal of neuroradiology·2014

Arterial spin-labeled perfusion of pediatric brain tumors.

AJNR. American journal of neuroradiology·2013

Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma.

Journal of neuro-oncology·2013

Malawi pilot study of Burkitt lymphoma treatment.

Medical and pediatric oncology·2003

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Medical and pediatric oncology·2003

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Medical and pediatric oncology·2003

Primary pulmonary NUT carcinoma: pathological features, clinical diagnosis, treatment, and prognosis - An extended review.

Oncology reviews·2026

Two cases of large cell neuroendocrine carcinoma of the gallbladder: case reports and systemic literature review.

Frontiers in medicine·2026

Alcohol consumption and cause-specific mortality in older men: Whitehall-1 study of London civil servants.

European journal of epidemiology·2026

De-escalation of Axillary Surgery in Early Breast Cancer: Translating SOUND and INSEMA into Clinical Practice.

Annals of surgery·2026

Testosterone and DHEA-S Secreting Adrenal Cortical Adenoma in a Postmenopausal Woman: A Rare Functional Incidentaloma.

Journal of investigative medicine high impact case reports·2026

Non-ampullary duodenal mixed neuroendocrine-non-neuroendocrine neoplasm initially diagnosed as adenocarcinoma: a case report.

International journal of surgery case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us